nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT1A1—lung cancer	0.25	0.482	CbGaD
Flunitrazepam—CYP2A6—lung cancer	0.157	0.303	CbGaD
Flunitrazepam—CYP2E1—lung cancer	0.112	0.215	CbGaD
Flunitrazepam—UGT1A1—Erlotinib—lung cancer	0.0436	0.133	CbGbCtD
Flunitrazepam—UGT1A1—Irinotecan—lung cancer	0.0394	0.12	CbGbCtD
Flunitrazepam—UGT1A1—Etoposide—lung cancer	0.0315	0.0963	CbGbCtD
Flunitrazepam—CYP2C19—Gefitinib—lung cancer	0.0181	0.0554	CbGbCtD
Flunitrazepam—CYP2C19—Teniposide—lung cancer	0.0176	0.0537	CbGbCtD
Flunitrazepam—CYP2B6—Irinotecan—lung cancer	0.0152	0.0465	CbGbCtD
Flunitrazepam—CYP2C9—Gefitinib—lung cancer	0.0151	0.046	CbGbCtD
Flunitrazepam—CYP2C9—Teniposide—lung cancer	0.0146	0.0446	CbGbCtD
Flunitrazepam—CYP2B6—Cisplatin—lung cancer	0.0124	0.0379	CbGbCtD
Flunitrazepam—CYP2E1—Etoposide—lung cancer	0.0124	0.0378	CbGbCtD
Flunitrazepam—CYP1A2—Erlotinib—lung cancer	0.00989	0.0302	CbGbCtD
Flunitrazepam—CYP3A4—Topotecan—lung cancer	0.00958	0.0293	CbGbCtD
Flunitrazepam—CYP3A4—Gefitinib—lung cancer	0.00876	0.0268	CbGbCtD
Flunitrazepam—CYP3A4—Teniposide—lung cancer	0.0085	0.0259	CbGbCtD
Flunitrazepam—CYP2B6—Doxorubicin—lung cancer	0.00832	0.0254	CbGbCtD
Flunitrazepam—CYP2C9—Paclitaxel—lung cancer	0.00816	0.0249	CbGbCtD
Flunitrazepam—CYP1A2—Etoposide—lung cancer	0.00715	0.0218	CbGbCtD
Flunitrazepam—CYP3A4—Vinorelbine—lung cancer	0.00675	0.0206	CbGbCtD
Flunitrazepam—CYP2C9—Cisplatin—lung cancer	0.00656	0.02	CbGbCtD
Flunitrazepam—CYP3A4—Crizotinib—lung cancer	0.00537	0.0164	CbGbCtD
Flunitrazepam—CYP3A4—Erlotinib—lung cancer	0.00518	0.0158	CbGbCtD
Flunitrazepam—CYP3A4—Paclitaxel—lung cancer	0.00474	0.0145	CbGbCtD
Flunitrazepam—CYP3A4—Irinotecan—lung cancer	0.00468	0.0143	CbGbCtD
Flunitrazepam—CYP3A4—Vinblastine—lung cancer	0.00416	0.0127	CbGbCtD
Flunitrazepam—CYP3A4—Etoposide—lung cancer	0.00375	0.0114	CbGbCtD
Flunitrazepam—CYP3A4—Docetaxel—lung cancer	0.00343	0.0105	CbGbCtD
Flunitrazepam—CYP3A4—Doxorubicin—lung cancer	0.00256	0.00781	CbGbCtD
Flunitrazepam—Balance disorder—Crizotinib—lung cancer	0.00251	0.0533	CcSEcCtD
Flunitrazepam—Slurred speech—Cisplatin—lung cancer	0.00108	0.0229	CcSEcCtD
Flunitrazepam—Diplopia—Crizotinib—lung cancer	0.000997	0.0211	CcSEcCtD
Flunitrazepam—Muscular weakness—Crizotinib—lung cancer	0.000879	0.0187	CcSEcCtD
Flunitrazepam—Dysarthria—Irinotecan—lung cancer	0.000562	0.0119	CcSEcCtD
Flunitrazepam—Sweating—Teniposide—lung cancer	0.000545	0.0116	CcSEcCtD
Flunitrazepam—Hiccups—Irinotecan—lung cancer	0.000532	0.0113	CcSEcCtD
Flunitrazepam—Dysarthria—Cisplatin—lung cancer	0.00051	0.0108	CcSEcCtD
Flunitrazepam—Angioedema—Gefitinib—lung cancer	0.000498	0.0106	CcSEcCtD
Flunitrazepam—Malaise—Gefitinib—lung cancer	0.000492	0.0104	CcSEcCtD
Flunitrazepam—Hiccups—Cisplatin—lung cancer	0.000483	0.0102	CcSEcCtD
Flunitrazepam—Dry mouth—Gefitinib—lung cancer	0.000454	0.00963	CcSEcCtD
Flunitrazepam—Fatigue—Crizotinib—lung cancer	0.000423	0.00896	CcSEcCtD
Flunitrazepam—Hypotension—Gefitinib—lung cancer	0.000416	0.00882	CcSEcCtD
Flunitrazepam—Muscular weakness—Vinorelbine—lung cancer	0.000413	0.00875	CcSEcCtD
Flunitrazepam—Agitation—Teniposide—lung cancer	0.000408	0.00866	CcSEcCtD
Flunitrazepam—Sweating—Topotecan—lung cancer	0.000404	0.00857	CcSEcCtD
Flunitrazepam—Fatigue—Pemetrexed—lung cancer	0.000386	0.00819	CcSEcCtD
Flunitrazepam—Fatigue—Gefitinib—lung cancer	0.000384	0.00814	CcSEcCtD
Flunitrazepam—Amnesia—Cisplatin—lung cancer	0.000373	0.00791	CcSEcCtD
Flunitrazepam—Confusional state—Teniposide—lung cancer	0.000366	0.00776	CcSEcCtD
Flunitrazepam—Tachycardia—Teniposide—lung cancer	0.000354	0.00751	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Irinotecan—lung cancer	0.000353	0.00748	CcSEcCtD
Flunitrazepam—Asthenia—Crizotinib—lung cancer	0.000352	0.00746	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Teniposide—lung cancer	0.000351	0.00744	CcSEcCtD
Flunitrazepam—Hypotension—Teniposide—lung cancer	0.000339	0.00719	CcSEcCtD
Flunitrazepam—Irritability—Cisplatin—lung cancer	0.000334	0.00709	CcSEcCtD
Flunitrazepam—Dizziness—Crizotinib—lung cancer	0.000324	0.00687	CcSEcCtD
Flunitrazepam—Asthenia—Pemetrexed—lung cancer	0.000321	0.00681	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Cisplatin—lung cancer	0.00032	0.00679	CcSEcCtD
Flunitrazepam—Asthenia—Gefitinib—lung cancer	0.000319	0.00677	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Vinblastine—lung cancer	0.000315	0.00667	CcSEcCtD
Flunitrazepam—Rash—Crizotinib—lung cancer	0.000309	0.00655	CcSEcCtD
Flunitrazepam—Dermatitis—Crizotinib—lung cancer	0.000309	0.00655	CcSEcCtD
Flunitrazepam—Malaise—Vinblastine—lung cancer	0.000306	0.00649	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Topotecan—lung cancer	0.000306	0.00648	CcSEcCtD
Flunitrazepam—Angioedema—Topotecan—lung cancer	0.000301	0.00638	CcSEcCtD
Flunitrazepam—Feeling abnormal—Teniposide—lung cancer	0.000299	0.00634	CcSEcCtD
Flunitrazepam—Malaise—Topotecan—lung cancer	0.000297	0.0063	CcSEcCtD
Flunitrazepam—Dizziness—Pemetrexed—lung cancer	0.000296	0.00628	CcSEcCtD
Flunitrazepam—Ataxia—Paclitaxel—lung cancer	0.000296	0.00628	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Paclitaxel—lung cancer	0.000287	0.0061	CcSEcCtD
Flunitrazepam—Discomfort—Vinblastine—lung cancer	0.000285	0.00605	CcSEcCtD
Flunitrazepam—Sweating—Irinotecan—lung cancer	0.000285	0.00605	CcSEcCtD
Flunitrazepam—Rash—Pemetrexed—lung cancer	0.000282	0.00599	CcSEcCtD
Flunitrazepam—Dermatitis—Pemetrexed—lung cancer	0.000282	0.00598	CcSEcCtD
Flunitrazepam—Rash—Gefitinib—lung cancer	0.000281	0.00595	CcSEcCtD
Flunitrazepam—Dermatitis—Gefitinib—lung cancer	0.00028	0.00595	CcSEcCtD
Flunitrazepam—Dysarthria—Methotrexate—lung cancer	0.00028	0.00594	CcSEcCtD
Flunitrazepam—Sweating—Gemcitabine—lung cancer	0.000278	0.00589	CcSEcCtD
Flunitrazepam—Muscular weakness—Paclitaxel—lung cancer	0.000278	0.00589	CcSEcCtD
Flunitrazepam—Discomfort—Topotecan—lung cancer	0.000277	0.00588	CcSEcCtD
Flunitrazepam—Anxiety—Erlotinib—lung cancer	0.000277	0.00587	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Vinorelbine—lung cancer	0.000261	0.00555	CcSEcCtD
Flunitrazepam—Asthenia—Teniposide—lung cancer	0.00026	0.00552	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Topotecan—lung cancer	0.00026	0.00551	CcSEcCtD
Flunitrazepam—Angioedema—Vinorelbine—lung cancer	0.000258	0.00546	CcSEcCtD
Flunitrazepam—Malaise—Vinorelbine—lung cancer	0.000254	0.00539	CcSEcCtD
Flunitrazepam—Ataxia—Docetaxel—lung cancer	0.000251	0.00532	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Docetaxel—lung cancer	0.000244	0.00517	CcSEcCtD
Flunitrazepam—Dysarthria—Doxorubicin—lung cancer	0.000243	0.00514	CcSEcCtD
Flunitrazepam—Discomfort—Vinorelbine—lung cancer	0.000237	0.00503	CcSEcCtD
Flunitrazepam—Fatigue—Topotecan—lung cancer	0.000232	0.00492	CcSEcCtD
Flunitrazepam—Hiccups—Doxorubicin—lung cancer	0.000229	0.00487	CcSEcCtD
Flunitrazepam—Fatigue—Erlotinib—lung cancer	0.000229	0.00486	CcSEcCtD
Flunitrazepam—Rash—Teniposide—lung cancer	0.000229	0.00485	CcSEcCtD
Flunitrazepam—Dermatitis—Teniposide—lung cancer	0.000229	0.00485	CcSEcCtD
Flunitrazepam—Feeling abnormal—Vinblastine—lung cancer	0.000228	0.00484	CcSEcCtD
Flunitrazepam—Headache—Teniposide—lung cancer	0.000227	0.00482	CcSEcCtD
Flunitrazepam—Tachycardia—Vinorelbine—lung cancer	0.000224	0.00476	CcSEcCtD
Flunitrazepam—Feeling abnormal—Topotecan—lung cancer	0.000222	0.0047	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Irinotecan—lung cancer	0.000216	0.00457	CcSEcCtD
Flunitrazepam—Hypotension—Vinorelbine—lung cancer	0.000215	0.00456	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Gemcitabine—lung cancer	0.00021	0.00446	CcSEcCtD
Flunitrazepam—Malaise—Irinotecan—lung cancer	0.00021	0.00445	CcSEcCtD
Flunitrazepam—Malaise—Gemcitabine—lung cancer	0.000204	0.00433	CcSEcCtD
Flunitrazepam—Asthenia—Vinblastine—lung cancer	0.000199	0.00421	CcSEcCtD
Flunitrazepam—Fatigue—Vinorelbine—lung cancer	0.000198	0.00421	CcSEcCtD
Flunitrazepam—Tremor—Cisplatin—lung cancer	0.000198	0.00419	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Cisplatin—lung cancer	0.000196	0.00415	CcSEcCtD
Flunitrazepam—Discomfort—Irinotecan—lung cancer	0.000196	0.00415	CcSEcCtD
Flunitrazepam—Asthenia—Topotecan—lung cancer	0.000193	0.00409	CcSEcCtD
Flunitrazepam—Confusional state—Irinotecan—lung cancer	0.000191	0.00406	CcSEcCtD
Flunitrazepam—Asthenia—Erlotinib—lung cancer	0.000191	0.00405	CcSEcCtD
Flunitrazepam—Discomfort—Gemcitabine—lung cancer	0.00019	0.00404	CcSEcCtD
Flunitrazepam—Malaise—Cisplatin—lung cancer	0.00019	0.00404	CcSEcCtD
Flunitrazepam—Feeling abnormal—Vinorelbine—lung cancer	0.00019	0.00402	CcSEcCtD
Flunitrazepam—Irritability—Methotrexate—lung cancer	0.000184	0.00389	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Irinotecan—lung cancer	0.000183	0.00389	CcSEcCtD
Flunitrazepam—Dizziness—Vinblastine—lung cancer	0.000183	0.00388	CcSEcCtD
Flunitrazepam—Acenocoumarol—ALB—lung cancer	0.000181	0.12	CrCbGaD
Flunitrazepam—Ataxia—Methotrexate—lung cancer	0.000181	0.00383	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Etoposide—lung cancer	0.000179	0.0038	CcSEcCtD
Flunitrazepam—Anxiety—Cisplatin—lung cancer	0.000179	0.0038	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Gemcitabine—lung cancer	0.000179	0.00379	CcSEcCtD
Flunitrazepam—Dizziness—Topotecan—lung cancer	0.000178	0.00377	CcSEcCtD
Flunitrazepam—Tremor—Paclitaxel—lung cancer	0.000178	0.00377	CcSEcCtD
Flunitrazepam—Discomfort—Cisplatin—lung cancer	0.000178	0.00376	CcSEcCtD
Flunitrazepam—Hypotension—Irinotecan—lung cancer	0.000177	0.00376	CcSEcCtD
Flunitrazepam—Dizziness—Erlotinib—lung cancer	0.000176	0.00373	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Paclitaxel—lung cancer	0.000176	0.00373	CcSEcCtD
Flunitrazepam—Malaise—Etoposide—lung cancer	0.000174	0.0037	CcSEcCtD
Flunitrazepam—Agitation—Paclitaxel—lung cancer	0.000174	0.00369	CcSEcCtD
Flunitrazepam—Headache—Vinblastine—lung cancer	0.000173	0.00368	CcSEcCtD
Flunitrazepam—Angioedema—Paclitaxel—lung cancer	0.000173	0.00367	CcSEcCtD
Flunitrazepam—Hypotension—Gemcitabine—lung cancer	0.000173	0.00366	CcSEcCtD
Flunitrazepam—Malaise—Paclitaxel—lung cancer	0.000171	0.00363	CcSEcCtD
Flunitrazepam—Rash—Topotecan—lung cancer	0.00017	0.0036	CcSEcCtD
Flunitrazepam—Dermatitis—Topotecan—lung cancer	0.000169	0.00359	CcSEcCtD
Flunitrazepam—Somnolence—Irinotecan—lung cancer	0.000169	0.00358	CcSEcCtD
Flunitrazepam—Headache—Topotecan—lung cancer	0.000168	0.00357	CcSEcCtD
Flunitrazepam—Tachycardia—Cisplatin—lung cancer	0.000168	0.00357	CcSEcCtD
Flunitrazepam—Rash—Erlotinib—lung cancer	0.000168	0.00356	CcSEcCtD
Flunitrazepam—Dermatitis—Erlotinib—lung cancer	0.000168	0.00355	CcSEcCtD
Flunitrazepam—Headache—Erlotinib—lung cancer	0.000167	0.00353	CcSEcCtD
Flunitrazepam—Diplopia—Doxorubicin—lung cancer	0.000167	0.00353	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Cisplatin—lung cancer	0.000167	0.00353	CcSEcCtD
Flunitrazepam—Asthenia—Vinorelbine—lung cancer	0.000165	0.0035	CcSEcCtD
Flunitrazepam—Somnolence—Gemcitabine—lung cancer	0.000164	0.00348	CcSEcCtD
Flunitrazepam—Fatigue—Irinotecan—lung cancer	0.000164	0.00347	CcSEcCtD
Flunitrazepam—Discomfort—Etoposide—lung cancer	0.000163	0.00345	CcSEcCtD
Flunitrazepam—Hypotension—Cisplatin—lung cancer	0.000161	0.00341	CcSEcCtD
Flunitrazepam—Anxiety—Paclitaxel—lung cancer	0.000161	0.00341	CcSEcCtD
Flunitrazepam—Discomfort—Paclitaxel—lung cancer	0.000159	0.00338	CcSEcCtD
Flunitrazepam—Fatigue—Gemcitabine—lung cancer	0.000159	0.00338	CcSEcCtD
Flunitrazepam—Confusional state—Etoposide—lung cancer	0.000159	0.00337	CcSEcCtD
Flunitrazepam—Clonazepam—CYP2E1—lung cancer	0.000159	0.106	CrCbGaD
Flunitrazepam—Dry mouth—Paclitaxel—lung cancer	0.000158	0.00335	CcSEcCtD
Flunitrazepam—Ataxia—Doxorubicin—lung cancer	0.000157	0.00332	CcSEcCtD
Flunitrazepam—Feeling abnormal—Irinotecan—lung cancer	0.000156	0.00332	CcSEcCtD
Flunitrazepam—Confusional state—Paclitaxel—lung cancer	0.000156	0.00331	CcSEcCtD
Flunitrazepam—Tachycardia—Etoposide—lung cancer	0.000154	0.00327	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Etoposide—lung cancer	0.000153	0.00324	CcSEcCtD
Flunitrazepam—Feeling abnormal—Gemcitabine—lung cancer	0.000152	0.00323	CcSEcCtD
Flunitrazepam—Dizziness—Vinorelbine—lung cancer	0.000152	0.00323	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Doxorubicin—lung cancer	0.000152	0.00323	CcSEcCtD
Flunitrazepam—Tachycardia—Paclitaxel—lung cancer	0.000151	0.0032	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Paclitaxel—lung cancer	0.00015	0.00317	CcSEcCtD
Flunitrazepam—Drowsiness—Methotrexate—lung cancer	0.000148	0.00314	CcSEcCtD
Flunitrazepam—Hypotension—Etoposide—lung cancer	0.000147	0.00313	CcSEcCtD
Flunitrazepam—Muscular weakness—Doxorubicin—lung cancer	0.000147	0.00311	CcSEcCtD
Flunitrazepam—Rash—Vinorelbine—lung cancer	0.000145	0.00308	CcSEcCtD
Flunitrazepam—Dermatitis—Vinorelbine—lung cancer	0.000145	0.00307	CcSEcCtD
Flunitrazepam—Hypotension—Paclitaxel—lung cancer	0.000145	0.00307	CcSEcCtD
Flunitrazepam—Flurazepam—CYP2A6—lung cancer	0.000144	0.0961	CrCbGaD
Flunitrazepam—Headache—Vinorelbine—lung cancer	0.000144	0.00306	CcSEcCtD
Flunitrazepam—Sweating—Methotrexate—lung cancer	0.000142	0.00301	CcSEcCtD
Flunitrazepam—Feeling abnormal—Cisplatin—lung cancer	0.000142	0.00301	CcSEcCtD
Flunitrazepam—Somnolence—Etoposide—lung cancer	0.00014	0.00297	CcSEcCtD
Flunitrazepam—Somnolence—Paclitaxel—lung cancer	0.000138	0.00292	CcSEcCtD
Flunitrazepam—Asthenia—Irinotecan—lung cancer	0.000136	0.00289	CcSEcCtD
Flunitrazepam—Fatigue—Etoposide—lung cancer	0.000136	0.00289	CcSEcCtD
Flunitrazepam—Dry mouth—Docetaxel—lung cancer	0.000134	0.00284	CcSEcCtD
Flunitrazepam—Fatigue—Paclitaxel—lung cancer	0.000133	0.00283	CcSEcCtD
Flunitrazepam—Asthenia—Gemcitabine—lung cancer	0.000133	0.00281	CcSEcCtD
Flunitrazepam—Confusional state—Docetaxel—lung cancer	0.000132	0.0028	CcSEcCtD
Flunitrazepam—Feeling abnormal—Etoposide—lung cancer	0.00013	0.00276	CcSEcCtD
Flunitrazepam—Drowsiness—Doxorubicin—lung cancer	0.000128	0.00272	CcSEcCtD
Flunitrazepam—Tachycardia—Docetaxel—lung cancer	0.000128	0.00271	CcSEcCtD
Flunitrazepam—Feeling abnormal—Paclitaxel—lung cancer	0.000127	0.0027	CcSEcCtD
Flunitrazepam—Dizziness—Irinotecan—lung cancer	0.000125	0.00266	CcSEcCtD
Flunitrazepam—Asthenia—Cisplatin—lung cancer	0.000124	0.00262	CcSEcCtD
Flunitrazepam—Sweating—Doxorubicin—lung cancer	0.000123	0.00261	CcSEcCtD
Flunitrazepam—Hypotension—Docetaxel—lung cancer	0.000123	0.0026	CcSEcCtD
Flunitrazepam—Rash—Irinotecan—lung cancer	0.00012	0.00254	CcSEcCtD
Flunitrazepam—Dermatitis—Irinotecan—lung cancer	0.000119	0.00253	CcSEcCtD
Flunitrazepam—Headache—Irinotecan—lung cancer	0.000119	0.00252	CcSEcCtD
Flunitrazepam—Somnolence—Docetaxel—lung cancer	0.000117	0.00247	CcSEcCtD
Flunitrazepam—Rash—Gemcitabine—lung cancer	0.000117	0.00247	CcSEcCtD
Flunitrazepam—Dermatitis—Gemcitabine—lung cancer	0.000116	0.00247	CcSEcCtD
Flunitrazepam—Headache—Gemcitabine—lung cancer	0.000116	0.00246	CcSEcCtD
Flunitrazepam—Nitrazepam—CYP2E1—lung cancer	0.000115	0.0767	CrCbGaD
Flunitrazepam—Asthenia—Etoposide—lung cancer	0.000113	0.0024	CcSEcCtD
Flunitrazepam—Fatigue—Docetaxel—lung cancer	0.000113	0.0024	CcSEcCtD
Flunitrazepam—Asthenia—Paclitaxel—lung cancer	0.000111	0.00235	CcSEcCtD
Flunitrazepam—Rash—Cisplatin—lung cancer	0.000109	0.0023	CcSEcCtD
Flunitrazepam—Dermatitis—Cisplatin—lung cancer	0.000108	0.0023	CcSEcCtD
Flunitrazepam—Ketazolam—ALB—lung cancer	0.000108	0.0722	CrCbGaD
Flunitrazepam—Feeling abnormal—Docetaxel—lung cancer	0.000108	0.00229	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Methotrexate—lung cancer	0.000107	0.00228	CcSEcCtD
Flunitrazepam—Malaise—Methotrexate—lung cancer	0.000104	0.00221	CcSEcCtD
Flunitrazepam—Dizziness—Etoposide—lung cancer	0.000104	0.00221	CcSEcCtD
Flunitrazepam—Ketazolam—ABCB1—lung cancer	0.000103	0.0689	CrCbGaD
Flunitrazepam—Flurazepam—CYP2E1—lung cancer	0.000102	0.0682	CrCbGaD
Flunitrazepam—Dizziness—Paclitaxel—lung cancer	0.000102	0.00217	CcSEcCtD
Flunitrazepam—Rash—Etoposide—lung cancer	9.95e-05	0.00211	CcSEcCtD
Flunitrazepam—Dermatitis—Etoposide—lung cancer	9.94e-05	0.00211	CcSEcCtD
Flunitrazepam—Headache—Etoposide—lung cancer	9.88e-05	0.0021	CcSEcCtD
Flunitrazepam—Rash—Paclitaxel—lung cancer	9.75e-05	0.00207	CcSEcCtD
Flunitrazepam—Dermatitis—Paclitaxel—lung cancer	9.75e-05	0.00207	CcSEcCtD
Flunitrazepam—Discomfort—Methotrexate—lung cancer	9.74e-05	0.00207	CcSEcCtD
Flunitrazepam—Headache—Paclitaxel—lung cancer	9.69e-05	0.00206	CcSEcCtD
Flunitrazepam—Confusional state—Methotrexate—lung cancer	9.53e-05	0.00202	CcSEcCtD
Flunitrazepam—Midazolam—CYP2E1—lung cancer	9.5e-05	0.0633	CrCbGaD
Flunitrazepam—Asthenia—Docetaxel—lung cancer	9.41e-05	0.002	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Doxorubicin—lung cancer	9.3e-05	0.00197	CcSEcCtD
Flunitrazepam—Agitation—Doxorubicin—lung cancer	9.21e-05	0.00195	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Methotrexate—lung cancer	9.14e-05	0.00194	CcSEcCtD
Flunitrazepam—Malaise—Doxorubicin—lung cancer	9.04e-05	0.00192	CcSEcCtD
Flunitrazepam—Hypotension—Methotrexate—lung cancer	8.83e-05	0.00187	CcSEcCtD
Flunitrazepam—Clonazepam—ALB—lung cancer	8.74e-05	0.0582	CrCbGaD
Flunitrazepam—Dizziness—Docetaxel—lung cancer	8.67e-05	0.00184	CcSEcCtD
Flunitrazepam—Anxiety—Doxorubicin—lung cancer	8.51e-05	0.0018	CcSEcCtD
Flunitrazepam—Discomfort—Doxorubicin—lung cancer	8.43e-05	0.00179	CcSEcCtD
Flunitrazepam—Somnolence—Methotrexate—lung cancer	8.4e-05	0.00178	CcSEcCtD
Flunitrazepam—Dry mouth—Doxorubicin—lung cancer	8.35e-05	0.00177	CcSEcCtD
Flunitrazepam—Rash—Docetaxel—lung cancer	8.27e-05	0.00175	CcSEcCtD
Flunitrazepam—Dermatitis—Docetaxel—lung cancer	8.26e-05	0.00175	CcSEcCtD
Flunitrazepam—Confusional state—Doxorubicin—lung cancer	8.25e-05	0.00175	CcSEcCtD
Flunitrazepam—Headache—Docetaxel—lung cancer	8.21e-05	0.00174	CcSEcCtD
Flunitrazepam—Fatigue—Methotrexate—lung cancer	8.15e-05	0.00173	CcSEcCtD
Flunitrazepam—Diazepam—CYP2E1—lung cancer	8.14e-05	0.0542	CrCbGaD
Flunitrazepam—Tachycardia—Doxorubicin—lung cancer	7.99e-05	0.00169	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Doxorubicin—lung cancer	7.91e-05	0.00168	CcSEcCtD
Flunitrazepam—Feeling abnormal—Methotrexate—lung cancer	7.79e-05	0.00165	CcSEcCtD
Flunitrazepam—Hypotension—Doxorubicin—lung cancer	7.65e-05	0.00162	CcSEcCtD
Flunitrazepam—Clobazam—ABCB1—lung cancer	7.31e-05	0.0487	CrCbGaD
Flunitrazepam—Somnolence—Doxorubicin—lung cancer	7.28e-05	0.00154	CcSEcCtD
Flunitrazepam—Fatigue—Doxorubicin—lung cancer	7.06e-05	0.0015	CcSEcCtD
Flunitrazepam—Asthenia—Methotrexate—lung cancer	6.78e-05	0.00144	CcSEcCtD
Flunitrazepam—Feeling abnormal—Doxorubicin—lung cancer	6.74e-05	0.00143	CcSEcCtD
Flunitrazepam—Dizziness—Methotrexate—lung cancer	6.25e-05	0.00133	CcSEcCtD
Flunitrazepam—Nitrazepam—ABCB1—lung cancer	6.04e-05	0.0402	CrCbGaD
Flunitrazepam—Rash—Methotrexate—lung cancer	5.96e-05	0.00126	CcSEcCtD
Flunitrazepam—Dermatitis—Methotrexate—lung cancer	5.95e-05	0.00126	CcSEcCtD
Flunitrazepam—Headache—Methotrexate—lung cancer	5.92e-05	0.00126	CcSEcCtD
Flunitrazepam—Asthenia—Doxorubicin—lung cancer	5.87e-05	0.00125	CcSEcCtD
Flunitrazepam—Dizziness—Doxorubicin—lung cancer	5.41e-05	0.00115	CcSEcCtD
Flunitrazepam—Flurazepam—ABCB1—lung cancer	5.37e-05	0.0358	CrCbGaD
Flunitrazepam—Rash—Doxorubicin—lung cancer	5.16e-05	0.00109	CcSEcCtD
Flunitrazepam—Dermatitis—Doxorubicin—lung cancer	5.16e-05	0.00109	CcSEcCtD
Flunitrazepam—Headache—Doxorubicin—lung cancer	5.13e-05	0.00109	CcSEcCtD
Flunitrazepam—Midazolam—ABCB1—lung cancer	4.98e-05	0.0332	CrCbGaD
Flunitrazepam—Diazepam—ALB—lung cancer	4.47e-05	0.0298	CrCbGaD
Flunitrazepam—Diazepam—ABCB1—lung cancer	4.27e-05	0.0284	CrCbGaD
Flunitrazepam—CYP2C19—Metabolism—HPGDS—lung cancer	5.26e-06	5.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ENO2—lung cancer	5.26e-06	5.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPP2R1B—lung cancer	5.22e-06	4.98e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2A7—lung cancer	5.22e-06	4.98e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTA1—lung cancer	5.18e-06	4.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALDOA—lung cancer	5.18e-06	4.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.15e-06	4.92e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CG—lung cancer	5.13e-06	4.9e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCC3—lung cancer	5.12e-06	4.89e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SDC4—lung cancer	5.11e-06	4.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTT1—lung cancer	5.1e-06	4.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—STK11—lung cancer	5.05e-06	4.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP1A1—lung cancer	5.05e-06	4.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2A6—lung cancer	5.04e-06	4.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GCLC—lung cancer	5.04e-06	4.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NCOA3—lung cancer	5.02e-06	4.79e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.02e-06	4.79e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ERCC2—lung cancer	5.01e-06	4.78e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKR1C1—lung cancer	4.96e-06	4.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—STK11—lung cancer	4.95e-06	4.72e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.94e-06	4.71e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTEN—lung cancer	4.92e-06	4.69e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADCY1—lung cancer	4.89e-06	4.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ABCG2—lung cancer	4.89e-06	4.66e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—POMC—lung cancer	4.88e-06	4.66e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CB—lung cancer	4.84e-06	4.62e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—UGT1A1—lung cancer	4.82e-06	4.6e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—lung cancer	4.79e-06	4.57e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ENO2—lung cancer	4.79e-06	4.57e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HPGDS—lung cancer	4.79e-06	4.57e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ENO1—lung cancer	4.78e-06	4.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.76e-06	4.55e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.76e-06	4.54e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CREBBP—lung cancer	4.76e-06	4.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.7e-06	4.48e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.7e-06	4.48e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—EP300—lung cancer	4.69e-06	4.47e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTP1—lung cancer	4.68e-06	4.46e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RRM1—lung cancer	4.65e-06	4.44e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA3—lung cancer	4.65e-06	4.44e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTT1—lung cancer	4.65e-06	4.44e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GNG11—lung cancer	4.64e-06	4.43e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.62e-06	4.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2A6—lung cancer	4.6e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GCLC—lung cancer	4.6e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTP1—lung cancer	4.58e-06	4.37e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.58e-06	4.37e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CAT—lung cancer	4.55e-06	4.34e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CD—lung cancer	4.51e-06	4.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAT—lung cancer	4.46e-06	4.25e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ALB—lung cancer	4.45e-06	4.25e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ABCB1—lung cancer	4.43e-06	4.22e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALDOA—lung cancer	4.42e-06	4.22e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—B4GALT5—lung cancer	4.37e-06	4.17e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ENO1—lung cancer	4.36e-06	4.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TYMS—lung cancer	4.35e-06	4.15e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.34e-06	4.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ABCB1—lung cancer	4.34e-06	4.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOA1—lung cancer	4.33e-06	4.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTM1—lung cancer	4.3e-06	4.1e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NCOA3—lung cancer	4.29e-06	4.1e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2E1—lung cancer	4.29e-06	4.09e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.28e-06	4.09e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TYMS—lung cancer	4.26e-06	4.06e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA4—lung cancer	4.25e-06	4.06e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NQO1—lung cancer	4.24e-06	4.04e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.22e-06	4.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTM1—lung cancer	4.21e-06	4.02e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTEN—lung cancer	4.18e-06	3.99e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADCY1—lung cancer	4.18e-06	3.99e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCG2—lung cancer	4.18e-06	3.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.15e-06	3.96e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA2—lung cancer	4.14e-06	3.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.11e-06	3.92e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HPGDS—lung cancer	4.1e-06	3.91e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ENO2—lung cancer	4.1e-06	3.91e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1A1—lung cancer	4.07e-06	3.89e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.07e-06	3.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ERCC2—lung cancer	4.04e-06	3.86e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.02e-06	3.83e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA1—lung cancer	4e-06	3.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP1A1—lung cancer	3.99e-06	3.81e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—EP300—lung cancer	3.99e-06	3.8e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTT1—lung cancer	3.97e-06	3.79e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ERCC2—lung cancer	3.96e-06	3.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CG—lung cancer	3.96e-06	3.77e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCC3—lung cancer	3.95e-06	3.77e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CB—lung cancer	3.93e-06	3.75e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GCLC—lung cancer	3.93e-06	3.75e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2A6—lung cancer	3.93e-06	3.75e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.91e-06	3.73e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2E1—lung cancer	3.91e-06	3.73e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—lung cancer	3.9e-06	3.72e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NQO1—lung cancer	3.86e-06	3.69e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKR1C1—lung cancer	3.83e-06	3.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—STK11—lung cancer	3.82e-06	3.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.78e-06	3.61e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—POMC—lung cancer	3.76e-06	3.59e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.75e-06	3.58e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ENO1—lung cancer	3.72e-06	3.55e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—UGT1A1—lung cancer	3.72e-06	3.55e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.71e-06	3.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CREBBP—lung cancer	3.67e-06	3.5e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.66e-06	3.49e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.59e-06	3.42e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GNG11—lung cancer	3.58e-06	3.42e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTP1—lung cancer	3.53e-06	3.37e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOA1—lung cancer	3.5e-06	3.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—STK11—lung cancer	3.48e-06	3.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CD—lung cancer	3.48e-06	3.32e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—lung cancer	3.47e-06	3.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAT—lung cancer	3.44e-06	3.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALB—lung cancer	3.43e-06	3.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOA1—lung cancer	3.42e-06	3.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.42e-06	3.26e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALDOA—lung cancer	3.41e-06	3.26e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTEN—lung cancer	3.4e-06	3.24e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ABCB1—lung cancer	3.35e-06	3.19e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2E1—lung cancer	3.34e-06	3.19e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NCOA3—lung cancer	3.31e-06	3.16e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NQO1—lung cancer	3.3e-06	3.15e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TYMS—lung cancer	3.29e-06	3.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.27e-06	3.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTM1—lung cancer	3.25e-06	3.1e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—EP300—lung cancer	3.24e-06	3.09e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.23e-06	3.09e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADCY1—lung cancer	3.22e-06	3.08e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCG2—lung cancer	3.22e-06	3.08e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTP1—lung cancer	3.22e-06	3.08e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.2e-06	3.06e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CG—lung cancer	3.19e-06	3.05e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HPGDS—lung cancer	3.16e-06	3.02e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ENO2—lung cancer	3.16e-06	3.02e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.14e-06	3e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAT—lung cancer	3.14e-06	2.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CG—lung cancer	3.13e-06	2.98e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.12e-06	2.98e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1A1—lung cancer	3.08e-06	2.94e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTT1—lung cancer	3.07e-06	2.93e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ERCC2—lung cancer	3.05e-06	2.91e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ABCB1—lung cancer	3.05e-06	2.91e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—POMC—lung cancer	3.04e-06	2.9e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CB—lung cancer	3.03e-06	2.89e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2A6—lung cancer	3.03e-06	2.89e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GCLC—lung cancer	3.03e-06	2.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—lung cancer	3e-06	2.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TYMS—lung cancer	3e-06	2.86e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—STK11—lung cancer	2.98e-06	2.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—POMC—lung cancer	2.98e-06	2.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTM1—lung cancer	2.96e-06	2.83e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CREBBP—lung cancer	2.96e-06	2.82e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—lung cancer	2.95e-06	2.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CREBBP—lung cancer	2.9e-06	2.77e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ENO1—lung cancer	2.87e-06	2.74e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—lung cancer	2.83e-06	2.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1A1—lung cancer	2.81e-06	2.68e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CD—lung cancer	2.81e-06	2.68e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.79e-06	2.67e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ERCC2—lung cancer	2.78e-06	2.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALB—lung cancer	2.77e-06	2.64e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTP1—lung cancer	2.75e-06	2.63e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CD—lung cancer	2.75e-06	2.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALB—lung cancer	2.71e-06	2.59e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAT—lung cancer	2.68e-06	2.56e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.66e-06	2.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOA1—lung cancer	2.64e-06	2.52e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTEN—lung cancer	2.62e-06	2.5e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCB1—lung cancer	2.61e-06	2.49e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2E1—lung cancer	2.58e-06	2.46e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TYMS—lung cancer	2.56e-06	2.44e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NQO1—lung cancer	2.55e-06	2.43e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTM1—lung cancer	2.53e-06	2.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.53e-06	2.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—EP300—lung cancer	2.5e-06	2.38e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CB—lung cancer	2.45e-06	2.33e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—lung cancer	2.42e-06	2.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CG—lung cancer	2.41e-06	2.3e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—lung cancer	2.41e-06	2.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOA1—lung cancer	2.41e-06	2.3e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP1A1—lung cancer	2.4e-06	2.29e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—lung cancer	2.4e-06	2.29e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CB—lung cancer	2.39e-06	2.29e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ERCC2—lung cancer	2.38e-06	2.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—lung cancer	2.37e-06	2.26e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.31e-06	2.2e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—STK11—lung cancer	2.3e-06	2.19e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—POMC—lung cancer	2.3e-06	2.19e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CREBBP—lung cancer	2.24e-06	2.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CG—lung cancer	2.2e-06	2.1e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTP1—lung cancer	2.13e-06	2.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CD—lung cancer	2.12e-06	2.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTEN—lung cancer	2.11e-06	2.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—POMC—lung cancer	2.09e-06	2e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALB—lung cancer	2.09e-06	2e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTEN—lung cancer	2.07e-06	1.97e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAT—lung cancer	2.07e-06	1.97e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOA1—lung cancer	2.06e-06	1.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CREBBP—lung cancer	2.04e-06	1.95e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—EP300—lung cancer	2.02e-06	1.92e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCB1—lung cancer	2.01e-06	1.92e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TYMS—lung cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—EP300—lung cancer	1.97e-06	1.88e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.97e-06	1.88e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—lung cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTM1—lung cancer	1.95e-06	1.86e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CD—lung cancer	1.93e-06	1.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALB—lung cancer	1.91e-06	1.82e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CG—lung cancer	1.88e-06	1.79e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1A1—lung cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CB—lung cancer	1.85e-06	1.76e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—lung cancer	1.85e-06	1.76e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ERCC2—lung cancer	1.84e-06	1.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—lung cancer	1.83e-06	1.75e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—POMC—lung cancer	1.79e-06	1.71e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CREBBP—lung cancer	1.74e-06	1.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CB—lung cancer	1.68e-06	1.61e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—lung cancer	1.67e-06	1.59e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CD—lung cancer	1.65e-06	1.58e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALB—lung cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTEN—lung cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOA1—lung cancer	1.59e-06	1.52e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—EP300—lung cancer	1.52e-06	1.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—lung cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—lung cancer	1.49e-06	1.42e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—lung cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTEN—lung cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CG—lung cancer	1.45e-06	1.38e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CB—lung cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—lung cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—EP300—lung cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—POMC—lung cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CREBBP—lung cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CD—lung cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALB—lung cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTEN—lung cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—lung cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—lung cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—EP300—lung cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—lung cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CB—lung cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—lung cancer	1.1e-06	1.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—lung cancer	1.03e-06	9.8e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTEN—lung cancer	9.6e-07	9.16e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—lung cancer	9.2e-07	8.78e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—EP300—lung cancer	9.16e-07	8.74e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—lung cancer	8.78e-07	8.38e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—lung cancer	8.39e-07	8.01e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—lung cancer	7.17e-07	6.84e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—lung cancer	6.77e-07	6.46e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—lung cancer	5.53e-07	5.28e-06	CbGpPWpGaD
